Molecular insights into angiotensin II type 1 and type 2 receptors: Expression, signaling and physiological function and clinical application of its antagonists

被引:38
作者
Matsubara, H [1 ]
Inada, M [1 ]
机构
[1] Kansai Med Univ, Dept Med 2, Div Endocrine Hypertens & Metab, Osaka 5708507, Japan
关键词
D O I
10.1507/endocrj.45.137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:137 / 150
页数:14
相关论文
共 93 条
[1]  
Asano K, 1997, CIRCULATION, V95, P1193
[2]   Angiotensin II signal transduction in vascular smooth muscle - Role of tyrosine kinases [J].
Berk, BC ;
Corson, MA .
CIRCULATION RESEARCH, 1997, 80 (05) :607-616
[3]   COUNTERPOINT - MOLECULAR ANALYSIS OF THE ANGIOTENSIN-II RECEPTOR [J].
BERNSTEIN, KE ;
ALEXANDER, RW .
ENDOCRINE REVIEWS, 1992, 13 (02) :381-386
[4]   THE ANGIOTENSIN-AT2 RECEPTOR STIMULATES PROTEIN TYROSINE PHOSPHATASE-ACTIVITY AND MEDIATES INHIBITION OF PARTICULATE GUANYLATE-CYCLASE [J].
BOTTARI, SP ;
KING, IN ;
REICHLIN, S ;
DAHLSTROEM, I ;
LYDON, N ;
DEGASPARO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) :206-211
[5]   A G-PROTEIN IS INVOLVED IN THE ANGIOTENSIN AT(2) RECEPTOR INHIBITION OF THE T-TYPE CALCIUM CURRENT IN NON-DIFFERENTIATED NG108-15 CELLS [J].
BUISSON, B ;
LAFLAMME, L ;
BOTTARI, SP ;
DEGASPARO, M ;
GALLOPAYET, N ;
PAYET, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1670-1674
[6]   ANGIOTENSIN RECEPTOR SUBTYPES IN RAT, RABBIT AND MONKEY TISSUES - RELATIVE DISTRIBUTION AND SPECIES DEPENDENCY [J].
CHANG, RSL ;
LOTTI, VJ .
LIFE SCIENCES, 1991, 49 (20) :1485-1490
[7]   CHARACTERIZATION OF [H-3] LOSARTAN RECEPTORS IN ISOLATED RAT GLOMERULI [J].
CHANSEL, D ;
VANDERMEERSCH, S ;
PHAM, P ;
ARDAILLOU, R .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 247 (02) :193-198
[8]   PROTEIN-KINASE-C AND PROTEIN-KINASE-A REGULATE THE EXPRESSION OF ANGIOTENSIN-II RECEPTOR MESSENGER-RNA IN SMOOTH-MUSCLE CELLS [J].
CHEN, X ;
NISHIMURA, J ;
HASNA, J ;
KOBAYASHI, S ;
SHIKASHO, T ;
KANAIDE, H .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (02) :175-183
[9]   ORAL-ADMINISTRATION OF DUP-753, A SPECIFIC ANGIOTENSIN-II RECEPTOR ANTAGONIST, TO NORMAL-MALE VOLUNTEERS - INHIBITION OF PRESSOR-RESPONSE TO EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II [J].
CHRISTEN, Y ;
WAEBER, B ;
NUSSBERGER, J ;
PORCHET, M ;
BORLAND, RM ;
LEE, RJ ;
MAGGON, K ;
SHUM, L ;
TIMMERMANS, PBMWM ;
BRUNNER, HR .
CIRCULATION, 1991, 83 (04) :1333-1342
[10]  
*CONSENSUS TRIAL S, 1987, NEW ENGL J MED, V315, P1429